Federation des caisses Desjardins du Quebec’s 60 Degrees Pharmaceuticals Warrant SXTPW Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio SXTPW Stock Details SXTPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,000	Closed	-$115	–	2832
2025 Q1	$115	Hold	5,000	–	–	﹤0.01%	2587
2024 Q4	$150	Hold	5,000	–	–	﹤0.01%	2466
2024 Q3	$210	Hold	5,000	–	–	﹤0.01%	2453
2024 Q2	$250	Hold	5,000	–	–	﹤0.01%	2310
2024 Q1	$380	Hold	5,000	–	–	﹤0.01%	2262
2023 Q4	$200	Hold	5,000	–	–	﹤0.01%	2263
2023 Q3	$1.75K	Buy	+5,000	New	+$2.15K	﹤0.01%	2089

Other funds holding SXTPW

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Torno Capital Cohasset, Massachusetts $725M AUM 62.71% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's SXTPW Position: Q2 2025 in Review

Federation des caisses Desjardins du Quebec sold out of 60 Degrees Pharmaceuticals Warrant (SXTPW) in Q2 2025, closing a stake of 5,000 shares — an estimated $115 sold.

Federation des caisses Desjardins du Quebec first reported a position in SXTPW in Q3 2023 and held it in 7 quarters. The position peaked at $1.75K in Q3 2023. 5 funds tracked by Wall St. Rank hold SXTPW as of Q2 2025.

Federation des caisses Desjardins du Quebec reported no remaining 60 Degrees Pharmaceuticals Warrant position as of Q2 2025 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 5,000 60 Degrees Pharmaceuticals Warrant shares in Q2 2025, an estimated $115.
Federation des caisses Desjardins du Quebec first reported a position in 60 Degrees Pharmaceuticals Warrant in Q3 2023 and held it in 7 quarters.
Federation des caisses Desjardins du Quebec's 60 Degrees Pharmaceuticals Warrant position peaked at $1.75K in Q3 2023.
5 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals Warrant as of Q2 2025.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2025, filed 14 Aug 2025.